Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- July 2012
- DOI:
- 10.1371/journal.pone.0041171
- Bibcode:
- 2012PLoSO...741171T